X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Biocon Ltd with SUVEN LIFE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON LTD vs SUVEN LIFE - Comparison Results

BIOCON LTD    Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON LTD SUVEN LIFE BIOCON LTD/
SUVEN LIFE
 
P/E (TTM) x 100.6 14.0 717.9% View Chart
P/BV x 8.2 3.3 246.7% View Chart
Dividend Yield % 0.2 0.5 28.7%  

Financials

 BIOCON LTD   SUVEN LIFE
EQUITY SHARE DATA
    BIOCON LTD
Mar-17
SUVEN LIFE
Mar-17
BIOCON LTD/
SUVEN LIFE
5-Yr Chart
Click to enlarge
High Rs1,162229 508.5%   
Low Rs483151 319.3%   
Sales per share (Unadj.) Rs194.642.7 455.6%  
Earnings per share (Unadj.) Rs34.46.9 502.3%  
Cash flow per share (Unadj.) Rs48.38.5 565.7%  
Dividends per share (Unadj.) Rs1.001.00 100.0%  
Dividend yield (eoy) %0.10.5 23.1%  
Book value per share (Unadj.) Rs241.952.4 461.6%  
Shares outstanding (eoy) m200.00127.28 157.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.24.4 95.1%   
Avg P/E ratio x23.927.7 86.2%  
P/CF ratio (eoy) x17.022.2 76.6%  
Price / Book Value ratio x3.43.6 93.9%  
Dividend payout %2.914.6 19.9%   
Avg Mkt Cap Rs m164,44024,158 680.7%   
No. of employees `0009.21.0 908.9%   
Total wages/salary Rs m7,470522 1,431.9%   
Avg. sales/employee Rs Th4,213.95,349.7 78.8%   
Avg. wages/employee Rs Th809.0513.5 157.5%   
Avg. net profit/employee Rs Th745.2858.1 86.8%   
INCOME DATA
Net Sales Rs m38,9115,435 715.9%  
Other income Rs m1,571211 744.8%   
Total revenues Rs m40,4825,646 717.0%   
Gross profit Rs m9,7951,291 758.9%  
Depreciation Rs m2,772214 1,294.7%   
Interest Rs m26057 457.7%   
Profit before tax Rs m8,3341,231 677.2%   
Minority Interest Rs m1630-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,616359 450.4%   
Profit after tax Rs m6,881872 789.2%  
Gross profit margin %25.223.7 106.0%  
Effective tax rate %19.429.2 66.5%   
Net profit margin %17.716.0 110.2%  
BALANCE SHEET DATA
Current assets Rs m40,4774,917 823.2%   
Current liabilities Rs m16,7831,186 1,415.0%   
Net working cap to sales %60.968.6 88.7%  
Current ratio x2.44.1 58.2%  
Inventory Days Days6062 95.9%  
Debtors Days Days8331 269.2%  
Net fixed assets Rs m45,0733,154 1,428.9%   
Share capital Rs m1,000127 785.5%   
"Free" reserves Rs m47,3776,543 724.1%   
Net worth Rs m48,3776,670 725.3%   
Long term debt Rs m21,082259 8,130.4%   
Total assets Rs m93,9428,157 1,151.7%  
Interest coverage x33.122.7 145.8%   
Debt to equity ratio x0.40 1,121.0%  
Sales to assets ratio x0.40.7 62.2%   
Return on assets %7.611.4 66.8%  
Return on equity %14.213.1 108.8%  
Return on capital %12.618.6 67.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m12,9884,996 260.0%   
Fx outflow Rs m7,899959 823.7%   
Net fx Rs m5,0894,037 126.1%   
CASH FLOW
From Operations Rs m6,4001,088 588.1%  
From Investments Rs m-4,985-3,107 160.5%  
From Financial Activity Rs m-1,775-300 591.3%  
Net Cashflow Rs m-473-2,319 20.4%  

Share Holding

Indian Promoters % 40.4 63.4 63.7%  
Foreign collaborators % 20.6 0.0 -  
Indian inst/Mut Fund % 8.4 0.0 -  
FIIs % 10.7 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 19.9 36.5 54.5%  
Shareholders   109,995 37,287 295.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON LTD With:   FULFORD INDIA  AUROBINDO PHARMA  IPCA LABS  WOCKHARDT LTD.  VENUS REMEDIES  

Compare BIOCON LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 262 Points Up; ONGC & Tata Steel Top Gainers(Closing)

Indian share markets ended the day on a strong note. At the closing bell, the BSE Sensex finished higher by 262 points. While, the NSE Nifty finished up by 91 points.

Related Views on News

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Beware the 5th year of the Modi Regime(The Honest Truth)

May 22, 2018

2017 was a great year for the market. You were rewarded for taking excessive risk. But Ajit Dayal believes 2018 will be different. You will be rewarded for doing the opposite. Read on to know more...

Beware of Inflated Stock Market Angels(Sector Info)

May 17, 2018

The stock of Vakrangee helps us understand why it's a bad idea to chase high-flying stocks.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON LTD SHARE PRICE


May 25, 2018 03:35 PM

TRACK BIOCON LTD

  • Track your investment in BIOCON LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

BIOCON LTD - ELDER PHARMA COMPARISON

COMPARE BIOCON LTD WITH

MARKET STATS